Makino Bunsho, Kobayashi Mii, Kimura Kuniko, Ishimatsu Makoto, Sakakibara Iwao, Higuchi Masami, Kubo Masayoshi, Sasaki Hiroshi, Okada Minoru
Kampo & Pharmacognosy Laboratory, Research and Development Division, Tsumura & Co., Ibaraki, Japan.
Planta Med. 2002 Mar;68(3):226-31. doi: 10.1055/s-2002-23129.
The aqueous extract of the Chinese crude drug Alismatis rhizoma, a dried rhizome of Alisma orientale Juzepczuk, exhibited in vitro inhibitory activities on angiotensin II and arginine vasopressin binding to their receptors. A fractionation study on the extract clarified that the known terpenoidal constituents; i.e., alisols A and B, 23-O-acetylalisol B, and alismol, were responsible for the activities. Furthermore, investigation of commercial samples of the crude drug demonstrated striking differences in their activities dependent on their locality of origin due to a difference in the amounts of these active principles. Therefore, the content of these principles could be utilized as a criteria of quality of the crude drug Alismatis rhizoma.
中药泽泻(东方泽泻干燥根茎)的水提取物在体外对血管紧张素II和精氨酸加压素与其受体的结合表现出抑制活性。对该提取物的分级分离研究表明,已知的萜类成分,即泽泻醇A和B、23-O-乙酰泽泻醇B以及泽泻醇,是这些活性的原因。此外,对该中药材商业样品的研究表明,由于这些活性成分含量的差异,其活性因产地不同而存在显著差异。因此,这些成分的含量可作为中药泽泻质量的一个标准。